Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose comparison of nalbuphine combined with sufentanil during recovery from general anesthesia in gynecologic laparoscopy
ChiCTR1800019070Phase 4Recruiting
- Sponsor
- Huai'an Second Hospital
- Start
- Nov 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of nalbuphine and sufentanil in postoperative pain and well-being (4 arms), sponsored by Huai'an Second Hospital. Primary endpoints: respiratory rate, tidal volume and 3 more. Started Nov 2018; status: recruiting.
02
Drugs
nalbuphinesufentanil
03
Conditions
postoperative painwell-being
Beyond the preview
Go deeper on ChiCTR1800019070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800019070.